BioPharma Resources

Drug Trial Radar · NCT07286058

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

A Phase 3, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Either Biologic DMARD-Naïve or Biologic DMARD-Experienced, Including Those With Inadequate Response to Biologic DMARDs

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,182 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,182

Planned (sponsor's estimate)

Start

Mar 11, 2026

Primary completion

Dec 18, 2029

Study completion Dec 18, 2029

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Dec 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Psoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is tolerated and how well it works in adults with PsA over a longer period of time. Adults who completed the 1-year (52-week) treatment period in one of the parent studies (TAK-279-PsA-3001 \[NCT06671483\] or TAK-279-PsA-3002 \[NCT06671496\]) may be able to join this continuation study (also called long-term extension or LTE study). All participants in this continuation study, will receive zasocitinib (lower or higher dose), once a day (QD). Each participant can be in this study for approximately 2 years (108 weeks). This includes a treatment period of up to 2 years (104 weeks) and a 1-month (4-week) follow-up period to monitor a participant's health.

Conditions

  • Psoriatic Arthritis

Interventions

  • ZasocitinibDrug

    Zasocitinib oral tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: From start of study drug administration up to follow-up (up to Week 108)
  2. Number of Participants With Adverse Events of Special Interest (AESI)Time frame: From start of study drug administration up to follow-up (up to Week 108)
  3. Number of Participants With Clinically Significant Changes in Vital Sign ValuesTime frame: From start of study drug administration up to follow-up (up to Week 108)
  4. Number of Participants With Clinically Significant Changes in Clinical Laboratory ValuesTime frame: From start of study drug administration up to follow-up (up to Week 108)

Locations

111 sites in 20 countries. Site status is shown where the registry gives one.

  • Jeffrey Loomer, MD Arizona Arthritis & Rheumatology Research

    Tucson, Arizona · Recruiting

  • First OC Dermatology Research Inc.

    Fountain Valley, California · Recruiting

  • Purushotham & Akther Kotha MD

    La Mesa, California · Recruiting

  • Triwest Research Associates LLC

    La Mesa, California · Recruiting

  • The Cohen Medical Centers

    Thousand Oaks, California · Recruiting

  • Denver Arthritis Clinic - Lowry

    Denver, Colorado · Recruiting

  • Direct Helpers Research Center

    Hialeah, Florida · Recruiting

  • Sweet Hope Research Specialty, Inc, d/b/a Neoclinical Research

    Hialeah, Florida · Recruiting

  • Bioresearch Partners

    Miami, Florida · Recruiting

  • IRIS Research and Development

    Plantation, Florida · Recruiting

  • Clinical Research of West Florida | Tampa

    Tampa, Florida · Recruiting

  • Klein and Associates, M.D., P.A.

    Hagerstown, Maryland · Recruiting

  • Michigan Rheumatology Group, P.C. - Grand Blanc Office

    Grand Blanc, Michigan · Recruiting

  • DJL Clinical Research

    Charlotte, North Carolina · Recruiting

  • Paramount Medical Research & Consulting, LLC

    Middleburg Heights, Ohio · Recruiting

  • West Tennessee Research Institute

    Jackson, Tennessee · Recruiting

  • Accurate Clinical Research

    Baytown, Texas · Recruiting

  • Novel Research LLC

    Bellaire, Texas · Recruiting

  • Novel Research | Abigail Neiman - Houston, TX

    Houston, Texas · Recruiting

  • Northwest Houston Arthritis Center

    Houston, Texas · Recruiting

  • West Texas Clinical Research

    Lubbock, Texas · Recruiting

  • Southwest Rheumatology Research, LLC

    Mesquite, Texas · Recruiting

  • Advanced Rheumatology of Houston

    The Woodlands, Texas · Recruiting

  • Centro de Investigaciones Reumatologicas

    San Miguel de Tucumán, Argentina · Recruiting

  • Sunshine Coast University Private Hospital

    Birtinya, Queensland, Australia · Recruiting

  • R.K. Will Pty Ltd

    Victoria Park, Western Australia, Australia · Recruiting

  • El Centro de Estudios Reumatologicos (CER)

    Providencia, Chile · Recruiting

  • Estudios Clinicos CTR

    Santiago, Chile · Recruiting

  • Clinica Dermacross S.A.

    Santiago, Chile · Recruiting

  • Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

    Chengdu, China · Recruiting

  • The First Affiliated Hospital Of Bengbu Medical College

    Bengbu, Anhui, China · Recruiting

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Guangzhou First People's Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Sun Yat-sen University - The Third Affiliated Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Shenzhen People's Hospital

    Shenzhen, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China · Recruiting

  • Union Hospital Tongji Medical College of Huazhong University of Science and Technology (HUST)

    Wuhan, Hubei, China · Recruiting

  • Central South University - Xiangya School of Medicine - Zhuzhou Central Hospital

    Zhuzhou, Hunan, China · Recruiting

  • The First Affiliated Hospital of Baotou Medical College

    Baotou Shi, Inner Mongolia, China · Recruiting

Showing 40 of 111 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.